Jerri Anstey
SubscribersAbout
Patients should be informed that the evidence is inconclusive whether testosterone therapy improves cognitive function, measures of diabetes, energy, fatigue, lipid profiles, and quality of life measures. Patients should be informed that testosterone therapy may result in improvements in erectile function, low sex drive, anemia, bone mineral density, lean body mass, and/or depressive symptoms. Men with testosterone deficiency who are interested in fertility should have a reproductive health evaluation performed prior to treatment.
The use of validated questionnaires is not currently recommended to either define which patients are candidates for testosterone therapy or to monitor symptom response in patients on testosterone therapy. Clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone. Also testosterone is known to stimulate growth of prostate cancer in men diagnosed with the condition. If a man's testosterone is below the normal range, it's best to repeat it once more to be sure before starting testosterone therapy - often staying on it indefinitely. It’s unlikely — and difficult to tell — that a male adult has higher-than-normal levels of testosterone. As testosterone in your blood increases, it suppresses the production of gonadotropin-releasing hormone, which helps maintain normal levels of testosterone. The inability to understand how this intervention works has hindered its widespread adoption as a mainstream therapeutic approach for prostate cancer patients.
The focused history should enquire for symptoms of hypogonadism, as well as symptoms that may reveal the presence of metabolic syndrome. Unfortunately, in a short term study by Takao et al.47 there was no difference in quality of life indices or LUTS in 21 men treated with TRT after 3 months. Compared to matched controls, there was no difference between the two groups in terms of IPSS, Qmax, PVR or prostate size. The concept, therefore, that treatment with TRT of hypogonadal males with metabolic syndrome might lead to improvement/stabilization of their LUTS, appears to be confirmed in recent work by Francomano et al.44 They published data in which 20 obese, hypogonadal men with metabolic syndrome were treated with TRT and followed for 5 years. Park et al.38 investigated a group of 1224 otherwise healthy police officers, 29% of whom were diagnosed with metabolic syndrome. Nonetheless, LUTS are a set of subjective and objective symptoms, the causes of which are multifactorial and generally not disease specific. Lower urinary tract symptoms in men are traditionally considered the ultimate clinical expression of BPH/BPE due to BOO.
For a long time, testosterone replacement therapy (TRT) was off the table. You might be feeling miserable with symptoms of low testosterone. You’d think that having high testosterone would put you at greater risk. Once the cancer cells have absorbed a small amount of testosterone, giving them more doesn’t really speed up their growth. Prostate cancer cells seem to work in a similar way with testosterone. The goal is to optimize quality of life while maintaining prostate health through appropriate screening and monitoring.
This study suggests it may be linked to progression, not the cause. This approach involves closely monitoring the cancer over time. Now, the same patches are being recast as a potential life-prolonging treatment for men. For years, debates around HRT have focused on its risks and benefits for women navigating menopause, with strong views on both sides.
The use of validated questionnaires is not currently recommended to either define which patients are candidates for testosterone therapy or to monitor symptom response in patients on testosterone therapy. Clinicians should use a total testosterone level below 300 ng/dL as a reasonable cut-off in support of the diagnosis of low testosterone. Also testosterone is known to stimulate growth of prostate cancer in men diagnosed with the condition. If a man's testosterone is below the normal range, it's best to repeat it once more to be sure before starting testosterone therapy - often staying on it indefinitely. It’s unlikely — and difficult to tell — that a male adult has higher-than-normal levels of testosterone. As testosterone in your blood increases, it suppresses the production of gonadotropin-releasing hormone, which helps maintain normal levels of testosterone. The inability to understand how this intervention works has hindered its widespread adoption as a mainstream therapeutic approach for prostate cancer patients.
The focused history should enquire for symptoms of hypogonadism, as well as symptoms that may reveal the presence of metabolic syndrome. Unfortunately, in a short term study by Takao et al.47 there was no difference in quality of life indices or LUTS in 21 men treated with TRT after 3 months. Compared to matched controls, there was no difference between the two groups in terms of IPSS, Qmax, PVR or prostate size. The concept, therefore, that treatment with TRT of hypogonadal males with metabolic syndrome might lead to improvement/stabilization of their LUTS, appears to be confirmed in recent work by Francomano et al.44 They published data in which 20 obese, hypogonadal men with metabolic syndrome were treated with TRT and followed for 5 years. Park et al.38 investigated a group of 1224 otherwise healthy police officers, 29% of whom were diagnosed with metabolic syndrome. Nonetheless, LUTS are a set of subjective and objective symptoms, the causes of which are multifactorial and generally not disease specific. Lower urinary tract symptoms in men are traditionally considered the ultimate clinical expression of BPH/BPE due to BOO.
For a long time, testosterone replacement therapy (TRT) was off the table. You might be feeling miserable with symptoms of low testosterone. You’d think that having high testosterone would put you at greater risk. Once the cancer cells have absorbed a small amount of testosterone, giving them more doesn’t really speed up their growth. Prostate cancer cells seem to work in a similar way with testosterone. The goal is to optimize quality of life while maintaining prostate health through appropriate screening and monitoring.
This study suggests it may be linked to progression, not the cause. This approach involves closely monitoring the cancer over time. Now, the same patches are being recast as a potential life-prolonging treatment for men. For years, debates around HRT have focused on its risks and benefits for women navigating menopause, with strong views on both sides.
